CD276 is a promising biomarker for the prognosis of clear cell renal cell carcinoma

Abstract This study aimed to investigate the role of cluster of differentiation 276 (CD276) in evaluating the prognosis of clear cell renal carcinoma (ccRCC) and to build a nomogram for predicting ccRCC progression post‐surgery. Using data downloaded from The Cancer Genome Atlas (TCGA) database, we...

Full description

Bibliographic Details
Main Authors: Yan‐Hang Yu, Jian‐Hao Xu, Hao Chen, Yu‐Xin Lin, Jun Ou‐Yang, Zhi‐Yu Zhang
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Online Access:https://doi.org/10.1002/kjm2.12891